Q1 2026 Revenio Group Oyj Earnings Call Transcript
Key Points
- Revenio Group Oyj (OHEL:REG1V) reported a net sales increase of 4.8% to EUR27.3 million, with a currency-adjusted growth of 8.4%, driven by strong performance in the USA and European markets.
- The Visionix transaction is expected to expand Revenio's addressable market from $1 billion to $2.5 billion, enhancing their product portfolio and market coverage.
- The company has implemented price increases starting February, which are expected to improve gross margins in the upcoming quarters.
- Revenio Group Oyj (OHEL:REG1V) maintains a strong equity ratio, which is expected to remain around 50% by the end of the year, even after the Visionix transaction.
- The company is targeting a EUR20 million EBITDA uplift by the end of 2029, with 70% of this expected by the end of 2027, indicating a clear long-term growth strategy.
- Operating profit decreased significantly to EUR2.4 million, primarily due to EUR3.1 million in one-off costs related to the Visionix transaction.
- The company's profitability has been impacted by lower margins, tariffs, and product mix changes, with gross margins remaining below 70%.
- APAC sales were slightly down due to tough comparables, although improvements are expected in Q2.
- Cash flow was not strong in Q1, influenced by high accounts receivable and tax payments.
- The company has withdrawn its prior guidance and will provide an adjusted outlook after the Visionix transaction closes, creating uncertainty for investors in the short term.
Good afternoon, and welcome to Revenio Group Q1 earnings call. My name is Jouni Toijala and I'm the group CFO for Revenio. And today we have a bit more bigger set of team members here. So, in addition to the normal. Robin Pulkkinen, our CFO; we also have Erkki Talla, Vice President products; in a call as well.
And the reason for that one is that we are going to run today a bit more longer earnings call. So of course, we are going to start with the Q1 financials and the business highlights. Then we go through the guidance part, which we actually don't have. But then we have a pretty extensive part run by Erkki regarding to the Visionix transaction, especially related to the products and the product portfolio. let's jump to the Q1. So reported net sales, EUR27.3 million. Increase on the reported side is 4.8%, Currency-adjusted net sales growth 8.4%. So, I think it's a good number, especially if taking into account the extremely strong start in the USA. So, in terms of the euros, of course, but
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
